The SUPREMO Trial - Pathology quality assurance of a large phase 3 randomised international clinical trial

被引:0
|
作者
Thomas, J. [1 ]
Hanby, A. [2 ]
Van Tienhoven, G. [3 ]
Russell, N. [4 ]
Riddle, K. [5 ]
Cameron, D. [6 ]
Bartlett, J. [7 ]
Piper, T. [6 ]
Cunningham, C. [6 ]
Canney, P. [8 ]
Kunkler, I. [6 ]
机构
[1] Nhs Lothian, Pathol, Edinburgh, Midlothian, Scotland
[2] Univ Leeds, Leeds Inst Canc Pathol, Pathol, Leeds, W Yorkshire, England
[3] Univ Amsterdam, Acad Med Ctr, Radiat Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[4] Antoni Van Leeuwenhoek Hosp Nki Avl, Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands
[5] Nhs Natl Serv Scotland, Scottish Clin Trials Res Unit, Scottish Clin Trials Res Unit, Edinburgh, Midlothian, Scotland
[6] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland
[7] Ontario Inst Canc Res, Maars, ON, Canada
[8] Univ Glasgow, Beetson Oncol Ctr, Glasgow, Lanark, Scotland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
192
引用
收藏
页码:S48 / S48
页数:1
相关论文
共 50 条
  • [1] The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer
    Thomas, J. S.
    Hanby, A. M.
    Russell, N.
    van Tienhoven, G.
    Riddle, K.
    Anderson, N.
    Cameron, D. A.
    Bartlett, J. M. S.
    Piper, T.
    Cunningham, C.
    Canney, P.
    Kunkler, I. H.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (01) : 63 - 69
  • [2] The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer
    J. S. Thomas
    A. M. Hanby
    N. Russell
    G. van Tienhoven
    K. Riddle
    N. Anderson
    D. A. Cameron
    J. M. S. Bartlett
    T. Piper
    C. Cunningham
    P. Canney
    I. H. Kunkler
    [J]. Breast Cancer Research and Treatment, 2017, 163 : 63 - 69
  • [3] On-trial radiotherapy quality assurance in NeoSCOPE: A randomised phase II trial of chemoradiotherapy in oesophageal cancer
    Evans, Elin
    Jones, Gareth
    Radhakrishna, Ganesh
    Hawkins, Maria A.
    Mukherjee, Somnath
    Maggs, Rhydian
    Ray, Ruby
    Crosby, Tom David Lewis
    Gwynne, Sarah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [4] Quality assurance metrics in clinical trial conduct
    Li, Jennifer
    Sellmann, Susanna
    Philip, Lindsay
    Guglielmi, Cristina
    Degendorfer, Pamela
    Oza, Amit M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [5] QUALITY ASSURANCE IN THE CHART CLINICAL-TRIAL
    AIRD, EGA
    WILLIAMS, C
    MOTT, GTM
    DISCHE, S
    SAUNDERS, MI
    [J]. RADIOTHERAPY AND ONCOLOGY, 1995, 36 (03) : 235 - 244
  • [6] Process maps in clinical trial quality assurance
    Rosen, Daniel H.
    Johnson, Sandra
    Kebaabetswe, Poloko
    Thigpen, Michael
    Smith, Dawn K.
    [J]. CLINICAL TRIALS, 2009, 6 (04) : 373 - 377
  • [7] The ARETTA Trial Experience: Radiotherapy Quality Assurance in an International Breast Cancer Trial
    Balogun, Onyinye
    Sowunmi, Anthonia
    Ntekim, Atara
    Alabi, Adewumi
    Olopade, Olufunmilayo I.
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [8] Quantitative quality assurance in a multicenter HARDI clinical trial at 3 T
    Zhou, Xiaopeng
    Sakaie, Ken E.
    Debbins, Josef P.
    Kirsch, John E.
    Tatsuoka, Curtis
    Fox, Robert J.
    Lowe, Mark J.
    [J]. MAGNETIC RESONANCE IMAGING, 2017, 35 : 81 - 90
  • [9] The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG)
    Lukovic, Jelena
    Moore, Alisha J.
    Lee, Mark T.
    Willis, David
    Ahmed, Shahida
    Akra, Mohamed
    Hortobagyi, Eszter
    Kron, Tomas
    Joon, Daryl Lim
    Liu, Amy
    Ryan, John
    Thomas, Melissa
    Wall, Katelyn
    Ward, Iain
    Wiltshire, Kirsty L.
    O'Callaghan, Chris J.
    Wong, Rebecca K. S.
    Ringash, Jolie G.
    Haustermans, Karin
    Leong, Trevor
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (05): : 1096 - 1106
  • [10] The Feasibility of Quality Assurance in the TOPGEAR International Phase III Clinical Trial of Neoadjuvant Chemoradiotherapy for Gastric Cancer (An Intergroup Trial of the AGITG/TROG/EORTC/CCTG)
    Lukovic, J.
    Moore, A. J.
    Lee, M. T.
    Willis, D.
    Ahmed, S.
    Akra, M.
    Hortobagyi, E.
    Joon, D. Lim
    Kron, T.
    Liu, Z.
    Ryan, J.
    Thomas, M.
    Wall, K.
    Ward, I.
    Wiltshire, K. L.
    O'Callaghan, C. J.
    Wong, R. K.
    Ringash, J. G.
    Haustermans, K.
    Leong, T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S38 - S39